In addition to our topic-specific e-newsletters, you can sign up for general News From PATH updates on our work. Photo: PATH.
In addition to our News From PATH general email updates for our friends and colleagues, PATH offers a number of topic-specific e-newsletters. Find out how to sign up below.
3D News: Perspectives on Defeating Diarrheal Disease
DefeatDD.org’s 3D News provides news and views for advocates, program implementers, policymakers, and anyone interested in the growing momentum for defeating the second leading killer of children worldwide. The newsletter offers the latest news on interventions and solutions, profiles of partners and success stories, summaries of recently published reports, upcoming events, and more.
DxNEWS, quarterly updates on our work in diagnostics
DxNEWS provides updates on PATH’s work in diagnostics, showcases the contributions of partners, tells stories about diagnostics in the field, and shares useful resources for the diagnostics community.
A Healthy Dose, quarterly updates on our drug development work
A Healthy Dose gives advocates, policymakers, government and agency leaders, and anyone interested in global health a quarterly update on our work in drug development. Each issue features reports from the field, news on the latest clinical trial milestones, and resources in nonprofit drug development.
HPVflash, a news bulletin on cervical cancer
HPVflash is an email news bulletin that disseminates useful cervical cancer prevention information, including updates on vaccines against the human papillomavirus, to interested persons worldwide. HPVflash emails are emailed only a few times a year.
Innovation for Global Health
Innovation for Global Health is a monthly newsletter published by the Global Health Technologies Coalition (GHTC). The newsletter includes updates on the latest in global health research and product development, with a focus on activities by US Congress, US federal agencies, the global health and development community, and GHTC members.
- View past issues on the GHTC website.
- Sign up for Innovation for Global Health with an email to firstname.lastname@example.org.
Introduction Planning Update, periodic news about the introduction of depo-subQ in Uniject
Introduction Planning Update is a periodic newsletter intended to share information with partners, advisors, and stakeholders of PATH’s Planning for Introduction of depo-subQ provera 104™ in the Uniject™ Injection System (depo-subQ in Uniject) project. Each issue contains updates on research, product registration, and introduction planning, and also provides information about related resources.
JE Newsbrief, a periodic update on expanding access to Japanese encephalitis vaccine
JE Newsbrief provides updates on the continued introduction and expansion of Japanese encephalitis vaccine in Southeast Asia and the Western Pacific, as well as the latest research and scientific data related to JE disease burden and vaccine safety and effectiveness.
Making Malaria History, a periodic update on our malaria control partnership
The Making Malaria History newsletter provides updates on the latest malaria research and news, provides advocates with timely data and resources, and shares evidence and field tools currently being used in malaria-endemic countries. Submissions and suggestions for articles are encouraged. To contact us, please email email@example.com.
- View past issues on the Making Malaria History site.
- Sign up for Making Malaria History on the Making Malaria History website by clicking on the “send me updates” link at the top of the site.
MVI Update, news from the PATH Malaria Vaccine Initiative
The Malaria Vaccine Initiative (MVI) provides news and updates to collaborators and partners through the MVI Update. Each issue opens with a letter from the director and provides articles about MVI’s work in malaria vaccine development and in preparing for vaccine availability and accessibility.
MVP News Digest, a quarterly update from the Meningitis Vaccine Project
MVP News Digest provides a quarterly update of activities at the Meningitis Vaccine Project (MVP), a partnership between the World Health Organization and PATH. MVP works to eliminate epidemic meningitis as a public health problem in sub-Saharan Africa through the advancement of a meningococcal conjugate vaccine. The digest offers news on vaccine development, clinical and surveillance activities, epidemiologic research, and vaccine introduction.
- View recent issues on the MVP website.
- Sign up for MVP News Digest with an email to firstname.lastname@example.org.
RotaFlash, breaking news on rotavirus disease and vaccines
RotaFlash provides breaking scientific news on rotavirus disease and vaccines and updates on progress toward increasing global access to vaccines against rotavirus, the leading cause of severe and fatal diarrhea in young children worldwide.
Saving Lives Through Better Data
Saving Lives Through Better Data provides quarterly updates on the Better Immunization Data (BID) Initiative's efforts to improve data collection, quality, and use. It includes updates on progress, partnerships, and specific activities.
Vaccines for the Future, a quarterly update from PATH’s vaccine development program
Vaccines for the Future provides quarterly updates on our efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against the leading causes of childhood deaths in developing-world populations, pneumonia (pneumococcal disease) and diarrheal disease (rotavirus, Shigella, enterotoxigenic Escherichia coli), as well as new vaccines for the global population against influenza, meningitis, and respiratory syncytial virus. It includes updates on our progress, partnerships, and specific activities.
Vaccine and Pharmaceutical Technologies News and Updates
Vaccine and Pharmaceutical Technologies News and Updates provides semiannual briefings on PATH’s work to advance innovative technologies that help improve vaccine and pharmaceutical products and the way they are delivered, especially in low-resource settings. The e-newsletter offers public health colleagues, technology partners, and other stakeholders a variety of scientific updates, programmatic announcements, upcoming event listings, and additional resources for further reading.